SCHEMBL11034052

SCHEMBL11034052

Cc1cc(CCCCCCCOc2ccc(C(=O)Cl)cc2)on1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP19A1 P11511 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
TP53 P04637 2/20 0.41
TSHR P16473 1/20 0.41
PLA2G4B P0C869 1/20 0.40
NPC1 O15118 3/20 0.39
RAB9A P51151 2/20 0.39
ALDH1A1 P00352 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ADRB2 P07550 1/20 0.39
NR1I2 O75469 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11031528 0.89 TP53 (0.55) GAATDP1TP53TSHRPLA2G4B
SCHEMBL11033892 0.89 TP53 (0.55) GAATDP1TP53TSHRPLA2G4B
SCHEMBL11033028 0.89 TP53 (0.55) GAATDP1TP53TSHRPLA2G4B
SCHEMBL11033909 0.89 GAA (0.60) GAACYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL11034638 0.89 TP53 (0.55) GAATDP1TP53TSHRPLA2G4B
SCHEMBL11033885 0.88 PARP10 (0.46) GAACYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL11032310 0.88 TP53 (0.52) GAATDP1TP53TSHRPLA2G4B
SCHEMBL11034168 0.87 CYP1A2 (0.45) GAACYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL11031023 0.87 MAPT (0.54) GAACYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL11030990 0.86 GPR119 (0.46) GAACYP1A2CYP19A1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0111345-A2 Isoxazoles, useful as antiviral agents, and preparation thereof STERLING DRUG INC. (US) 1984-06-20 EP disclosed
US-4451476-A Isoxazoles as antiviral agents STERLING DRUG INC. (US) 1984-05-29 US disclosed